ADVINA HEALTHCARE LIMITED
Opportunity 71/100 (strong), bankability 75/100. High owner-dependency — earn-out structure likely required for clean transition. Share purchase looks the cleaner deal structure. Most likely exit: strategic trade sale (65/100).
Data confidence
Overall: high (80/100)Strong data coverage across all sections. AI outputs should be trusted with minimal caveats.
Solid opportunity signal. Worth a dedicated memo and management meeting.
Signals from accounts
Derived from iXBRL accounts · accounting standard not declaredKey financials
2 years extracted from filed iXBRL accountsHover to see exact values · click legend to toggle series
Financials
Extracted from Companies House accounts · accounting standard unknown| Metric | 2025-03-31 | 2024-03-31 |
|---|---|---|
| Total assets | £206.0k | £186.6k |
| Current assets | £214.9k | £212.6k |
| Net assets | £206.0k | £186.6k |
Amounts extracted automatically from iXBRL. Fields left blank were not reported or not mapped. Values in GBP unless stated.
Recent activity
- • 2 address
- • 2 address
- • 1 confirmation-statement
Corporate timeline (22 events)Click to expand
- 2026-05-28📍change-registered-office-address-company-with-date-old-address-new-addressaddress · AD01
- 2026-05-26📍change-registered-office-address-company-with-date-old-address-new-addressaddress · AD01
- 2025-10-07📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2025-05-30📍change-registered-office-address-company-with-date-old-address-new-addressaddress · AD01
- 2025-05-30📄administrative-restoration-companyrestoration · RT01
- 2025-05-06📄gazette-dissolved-compulsorygazette · GAZ2
- 2025-03-14📄dissolved-compulsory-strike-off-suspendeddissolution · DISS16(SOAS)
- 2025-02-18📄gazette-notice-compulsorygazette · GAZ1
- 2024-12-11📄change-to-a-person-with-significant-controlpersons-with-significant-control · PSC04
- 2024-12-11📄change-person-director-company-with-change-dateofficers · CH01
- 2024-12-11📄change-person-director-company-with-change-dateofficers · CH01
- 2024-11-20📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2023-12-31📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2023-07-08📄gazette-filings-brought-up-to-dategazette · DISS40
- 2023-05-23📄gazette-notice-compulsorygazette · GAZ1
- 2023-04-26📍default-companies-house-registered-office-address-appliedaddress · RP05
- 2023-01-06📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2021-04-28📍change-registered-office-address-company-with-date-old-address-new-addressaddress · AD01
- 2021-03-03📄cessation-of-a-person-with-significant-controlpersons-with-significant-control · PSC07
- 2021-03-02🏢Company incorporatedAs ADVINA HEALTHCARE LIMITED
- 2021-03-02➕KANWAR, Sumita, Dr appointeddirector
- 2021-03-02➕MANSINGH, Ajay, Dr appointeddirector
Owner dependency
Material founder dependency. Consider a 2-3 year earn-out and build in a handover plan before completion.
- +Two-director setup: Only two active directors — typical of owner-managed SMEs but limits succession.
- +No director turnover: Company is 5 years old with no director changes — suggests a very tight-knit founder team never broadened.
Succession & seller-readiness
Limited succession signal. Not a near-term off-market candidate.
- secondaryTwo-director governance: Small-team governance. Succession depth is thin but not absent.
Red flags
1 lowMultiple address changes in a short period can indicate operational instability or admin disorder.
Shareholders & ownership
1 active beneficial owner| Name | Shares | Voting rights | Nature of control | Notified |
|---|---|---|---|---|
Dr Sumita Kanwar Individual · British · DOB 09/1978 · age 48 | 25–50% | 25–50% | 25-50% shares · 25-50% voting | 02/03/2021 |
1 historic (ceased) PSC
- Dr Ajay Mansinghceased 03/03/2021· 25-50% shares · 25-50% voting
From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.
Radial SVG graph showing every company connected via shared directors, colour-coded by status.
Available from the Pro tier upwards.
See pricing →Similar companies
Active · Healthcare & medical · HA postcode area| Company | Est. value | Turnover | Net worth | Staff | Age | Opp | Director |
|---|---|---|---|---|---|---|---|
| ACTIVE EVOLUTION LIMITED→ 10788669 · est 2017 · no financials extracted | — | — | — | — | 8y | — | — |
| ADAMDIMA LTD→ 13144558 · est 2021 · no financials extracted | — | — | — | — | 5y | — | — |
| ADONIS LONDON COSMETICS LTD→ 11643656 · est 2018 · no financials extracted | — | — | — | — | 7y | — | — |
| ADS WDC LIMITED→ 13476101 · est 2021 · no financials extracted | — | — | — | — | 4y | — | — |
| ADVANCE PLASTIC SURGERY LIMITED→ 15707546 · est 2024 · no financials extracted | — | — | — | — | 1y | — | — |
| ADVANCED RHEUMATOLOGY LIMITED→ 07994182 · est 2012 · no financials extracted | — | — | — | — | 14y | — | — |
| AEN HEALTHCARE LIMITED→ 10427885 · est 2016 · no financials extracted | — | — | — | — | 9y | — | — |
| AESTHETIC EDGE LTD→ 08902302 · est 2014 · no financials extracted | — | — | — | — | 12y | — | — |
| AESTHETIC LOUNGE LONDON LIMITED→ 14019974 · est 2022 · no financials extracted | — | — | — | — | 4y | — | — |
| AESTHETIC PLASTIC SURGERY LTD→ 04412624 · est 2002 · no financials extracted | — | — | — | — | 24y | — | — |
| AESTHETICARE BY PA LTD→ 16426658 · est 2025 · no financials extracted | — | — | — | — | — | — | — |
| AESTHETICS AND HOLISTIC LIMITED→ 15902112 · est 2024 · no financials extracted | — | — | — | — | 1y | — | — |
6 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.
Available from the Pro tier upwards.
See pricing →Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.
Available from the Pro tier upwards.
See pricing →Company details
Registered office
Filing status
Officers (2 active · 0 resigned)
Click a director name to see their full track record across all companies.